What's in Swiss Paraplegic Research, Nottwil's pipeline?

Swiss Paraplegic Research, Nottwil has 6 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Swiss Paraplegic Research, Nottwil's portfolio?

Top competitors by shared drug class: AbbVie, Ahmed AbdelMoneim Hassan Ali, Allergan, Amir Moradi MD, MBA, Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/swiss-paraplegic-research-nottwil.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Swiss Paraplegic Research, Nottwil — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Swiss Paraplegic Research, Nottwil pipeline: 3 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Uro-Vaxom	Uro-Vaxom	marketed
Polyhexanide	Polyhexanide	marketed			Other
Rivaroxaban Oral Tablet	Rivaroxaban Oral Tablet	marketed	Direct Factor Xa inhibitor	Factor Xa	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Neurology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Ahmed AbdelMoneim Hassan Ali · 1 shared drug class
Allergan · 1 shared drug class
Amir Moradi MD, MBA · 1 shared drug class
Bayer · 1 shared drug class
Beth Israel Deaconess Medical Center · 1 shared drug class
Chang Gung Memorial Hospital · 1 shared drug class
ASIS Corporation · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Swiss Paraplegic Research, Nottwil:

Cite this brief

Drug Landscape (2026). Swiss Paraplegic Research, Nottwil — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/swiss-paraplegic-research-nottwil. Accessed 2026-05-17.